Induced expression of the antimicrobial peptide melittin inhibits experimental infection by Mycoplasma gallisepticum in chickens

Microbes and Infection

Volumn 6, Issue 6, 2004, Pages 536-541

  Lazarev, Vassili N ^a,b   Stipkovits, Laszlo ^c   Biro, Judit ^c   Miklodi, Dora ^c   Shkarupeta, Marina M ^a,b   Titova, Galina A ^b   Akopian, Tatiana A ^b   Govorun, Vadim M ^a,b  

^a N N BLOKHIN NATIONAL MEDICAL RESEARCH CENTER OF ONCOLOGY   (Russian Federation)

^b Lytech Ltd   (Russian Federation)

^c Veterinary Medical Research Institute Hungarian Academy of Science   (Hungary)

Author keywords

Melittin; Mycoplasma gallisepticum; Recombinant plasmid vector

Indexed keywords

ANTIINFECTIVE AGENT; MELITTIN; PEPTIDE; PLASMID VECTOR;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIBACTERIAL ACTIVITY; ARTICLE; BACTERIAL INFECTION; BACTERIUM ISOLATE; CHICKEN; CLINICAL EXAMINATION; CONTROLLED STUDY; DRUG ACTIVITY; DRUG EFFECT; DRUG EFFICACY; DRUG MECHANISM; EXPERIMENTAL INFECTION; FREQUENCY ANALYSIS; HISTOPATHOLOGY; INFECTION CONTROL; INFECTION PREVENTION; INFECTION RISK; MYCOPLASMA GALLISEPTICUM; NONHUMAN; NUCLEOTIDE SEQUENCE; POULTRY FARMING; PRIORITY JOURNAL; PROMOTER REGION; RESPIRATORY TRACT INFECTION; SEROLOGY; TRANSACTIVATION;

AIR SACS; ANIMALS; ANTIBODIES, BACTERIAL; CHICKENS; GENE THERAPY; GENETIC VECTORS; HEART; KIDNEY; LIVER; LUNG; MELITTEN; MYCOPLASMA GALLISEPTICUM; MYCOPLASMA INFECTIONS; PLASMIDS; POULTRY DISEASES; RESPIRATORY MUCOSA; SPLEEN; TRACHEA;

CYTOMEGALOVIRUS; GALLUS GALLUS; HUMAN HERPESVIRUS 5; MYCOPLASMA; MYCOPLASMA GALLISEPTICUM;

EID: 2542422999     PISSN: 12864579     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.micinf.2004.02.006     Document Type: Article

References (28)

1. Jordan F.T.W. Tully J.G., Whitcomb R.F. The Mycoplasmas. 1979;1-48 Academic Press, New York
2. Davidson W.R., Nettles V.F., Couvillion C.E., Yoder H.W. Jr. Infectious sinusitis in wild turkeys. Avian Dis. 26:1982;402-405
3. Mohammed H.O., Carpenter T.E., Yamamoto R. Economic impact of Mycoplasma gallisepticum and M. synoviae in commercial layer flocks. Avian Dis. 31:1987;477-482
4. Nunoya T., Yagihashi T., Tajima M., Nagasawa Y. Occurrence of keratoconjunctivitis apparently caused by Mycoplasma gallisepticum in layer chickens. Vet. Pathol. 32:1995;11-18
5. Nunoya T., Kanai K., Yagihashi T., Hoshi S., Shibuya K., Tajima M. Natural case of salpingitis apparently caused by Mycoplasma gallisepticum in chickens. Avian Pathol. 26:1997;391-398
6. Lamas da Silva J.M., Adler H.E. Pathogenesis of arthritis induced in chickens by Mycoplasma gallisepticum. Pathol. Vet. 6:1969;385-395
7. Thomas L., Davidson M., McClusky R.T. Studies of PPLO infection. I. The production of cerebral polyarthritis by Mycoplasma gallisepticum in turkeys; the neurotoxic property of the mycoplasma. J. Exp. Med. 123:1966;897-912
8. Soeripto, Whithear K.G., Cottew G.S., Harrigan K.E. Virulence and transmissibility of Mycoplasma gallisepticum. Aus. Vet. J. 66:1989;65-72
9. Ley D.H., Yoder H.W. Jr. Mycoplasma gallisepticum infection. Calnek B.W. Diseases of Poultry. 1997;194-195 Iowa State University Press, Ames
10. Jordan F.T.W., Gilbert S., Knight D.L., Yavari C.A. Effects of Baytril, tylosin and tiamulin on avian mycoplasmas. Avian Pathol. 18:1989;659-673
11. Gautier-Bouchardon A.V., Reinhardt A.K., Kobisch M., Kempf I. In vitro development of resistance to enrofloxacin, erythromycin, tylosin, tiamulin and oxytetracycline in Mycoplasma gallisepticum, Mycoplasma iowae and Mycoplasma synoviae. Vet. Microbiol. 88:2002;47-58
12. Zasloff M. Antimicrobial peptides of multicellular organisms. Nature. 415:2002;389-395
13. Boman H.G. Peptide antibiotics and their role in innate immunity. Ann. Rev. Immunol. 13:1995;61-92
14. Bechinger B. Structure and functions of channel-forming peptides: magainins, cecropins, melittin and alamethicin. J. Membr. Biol. 156:1997;197-211
15. Devine D.A., Hancock R.E.W. Cationic peptides: distribution and mechanisms of resistance. Curr. Pharm. Des. 8:2002;703-714
16. Hancock R.E.W., Patrzykat A. Clinical development of cationic antimicrobial peptides: from natural to novel antibiotics. Curr. Drug. Targets Infect. Disord. 2:2002;79-83
17. Beven L., Wroblewski H. Effect of natural amphipathic peptides on viability, membrane potential, cell shape and motility of mollicutes. Res. Microbiol. 14:1997;163-175
18. Beven L., Castano S., Dufourcq J., Wieslander A., Wroblewski H. The antibiotic activity of cationic linear amphipathic peptides: lessons from the action of leucine/lysine copolymers on bacteria of the class Mollicutes. Eur. J. Biochem. 270:2003;2207-2217
19. Hancock R.E.W., Lehrer R. Cationic peptides: a new source of antibiotics. Trends Biotechnol. 16:1998;82-88
20. Erno H., Stipkovits L. Bovine mycoplasmas: cultural and biochemical studies. Acta Vet. Scand. 14:1973;436-449
21. Czifra G., Sundquist B., Tuboly T., Stipkovits L. Evaluation of a monoclonal blockingenzyme-linked immunosorbent assay for the detection of Mycoplasma gallisepticum-specific antibodies. Avian Dis. 37:1993;680-688
22. Whithear K.G., Harrigan K.E., Kleven S.H. Standardised method of aerosol challenge for testing the efficacy of Mycoplasma gallisepticum vaccines. Avian Dis. 40:1996;654-660
23. Whithear K.G. Corner L.A., Bagust T.J. Australian Standard Diagnostic Techniques for Animal Diseases. 1993;1-12 Common-Wealth Scientific and Industrial Research Organisation for the Standing Committee on Agriculture and Resource Management, Melbourne
24. Lazarev V.N., Parfenova T.M., Gularyan S.K., Misyurina O.Y., Akopian T.A., Govorun V.M. Induced expression of melittin, an antimicrobial peptide, inhibits infection by Chlamydia trachomatis and Mycoplasma hominis in a HeLa cell line. Int. J. Antimicrob. Agents. 19:2002;133-137
25. Gossen M., Bujard H. Tight control of gene expression in mammalian cells by tetracycline responsive promoters. Proc. Natl. Acad. Sci. USA. 89:1992;5547-5551
26. Nir-Paz R., Prevost M.C., Nicolas P., Blanchard A., Wroblewski H. Susceptibilities of Mycoplasma fermentans and Mycoplasma hyorhinis to membrane-active peptides and enrofloxacin in human tissue cell cultures. Antimicrob. Agents Chemother. 46:2002;1218-1225
27. Razin S., Jacobs E. Mycoplasma adhesion. J. Gen. Microbiol. 138:1992;407-422
28. Yokum T.S., Hammer R.P., McLaughlin M.L., Elzer P.H. Peptides with indirect in vivo activity against an intracellular pathogen: selective lysis of infected macrophages. J. Pept. Res. 59:2002;9-17